TransThera Sciences (Nanjing), Inc. (02617) at a glance
Code
02617
Company
TransThera Sciences (Nanjing), Inc.
Local name
TRANSTHERA-B
Market
Hong Kong Stock Exchange (H-share)
Share price
HK$7.98 -0.18 (-2.21%)Nov 12 close
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
TransThera Sciences (Nanjing), Inc. (02617) Stock Price HistoryNear a 52-week low
TransThera Sciences (Nanjing), Inc. closed at HK$7.98 on Nov 12, 2026, −20.3% over 1 month, −96.2% over 1 year.
Price5-day MA25-day MAHang Seng IndexDisclosures
1-Month HighHK$10.00Oct 12
1-Month LowHK$7.81Nov 3
1-Week Change−4.4%vs Nov 5
1-Month Change−20.3%vs Oct 12
If you had invested HK$10,000 1 month ago, it would be worth HK$7,975 today (−20.3%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −1.1%, while this stock moved −20.3%.
Last 10 Trading Days
Date
Close
Change
% Change
Nov 12 (Thu)
HK$7.98
−0.18
−2.21%
Nov 11 (Wed)
HK$8.16
−0.13
−1.51%
Nov 10 (Tue)
HK$8.28
+0.24
+2.99%
Nov 9 (Mon)
HK$8.04
−0.05
−0.56%
Nov 6 (Fri)
HK$8.09
−0.26
−3.12%
Nov 5 (Thu)
HK$8.35
+0.42
+5.23%
Nov 4 (Wed)
HK$7.93
+0.12
+1.54%
Nov 3 (Tue)
HK$7.81
−0.09
−1.14%
Nov 2 (Mon)
HK$7.90
−0.50
−5.95%
Oct 30 (Fri)
HK$8.40
−0.25
−2.95%
Price5-day MA25-day MAHang Seng IndexDisclosures
3-Month HighHK$11.12Sep 21
3-Month LowHK$7.81Nov 3
1-Month Change−20.3%vs Oct 12
3-Month Change−25.1%vs Aug 12
If you had invested HK$10,000 3 months ago, it would be worth HK$7,488 today (−25.1%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −5.6%, while this stock moved −25.1%.
Last 10 Trading Days
Date
Close
Change
% Change
Nov 12 (Thu)
HK$7.98
−0.18
−2.21%
Nov 11 (Wed)
HK$8.16
−0.13
−1.51%
Nov 10 (Tue)
HK$8.28
+0.24
+2.99%
Nov 9 (Mon)
HK$8.04
−0.05
−0.56%
Nov 6 (Fri)
HK$8.09
−0.26
−3.12%
Nov 5 (Thu)
HK$8.35
+0.42
+5.23%
Nov 4 (Wed)
HK$7.93
+0.12
+1.54%
Nov 3 (Tue)
HK$7.81
−0.09
−1.14%
Nov 2 (Mon)
HK$7.90
−0.50
−5.95%
Oct 30 (Fri)
HK$8.40
−0.25
−2.95%
Price25-day MA75-day MAHang Seng IndexDisclosures
6-Month HighHK$52.85May 12
6-Month LowHK$7.81Nov 3
3-Month Change−25.1%vs Aug 12
6-Month Change−84.9%vs May 12
If you had invested HK$10,000 6 months ago, it would be worth HK$1,509 today (−84.9%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −8.9%, while this stock moved −84.9%.
Monthly Closes
Month
Month-End Close
Monthly %
Nov 2026
HK$7.98
−5.1%
Oct 2026
HK$8.40
−23.2%
Sep 2026
HK$10.94
+7.6%
Aug 2026
HK$10.17
+2.2%
Jul 2026
HK$9.95
−13.9%
Jun 2026
HK$11.55
−67.0%
May 2026
HK$35.02
−32.1%
Price25-day MA75-day MAHang Seng IndexDisclosures
52-Week HighHK$215.00Nov 20
52-Week LowHK$7.81Nov 3
Year to Date−93.1%vs Dec 31
From 52-Week High−96.3%Nov 20
If you had invested HK$10,000 1 year ago, it would be worth HK$379 today (−96.2%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −10.8%, while this stock moved −96.2%.
Monthly Closes
Month
Month-End Close
Monthly %
Nov 2026
HK$7.98
−5.1%
Oct 2026
HK$8.40
−23.2%
Sep 2026
HK$10.94
+7.6%
Aug 2026
HK$10.17
+2.2%
Jul 2026
HK$9.95
−13.9%
Jun 2026
HK$11.55
−67.0%
May 2026
HK$35.02
−32.1%
Apr 2026
HK$51.60
−22.4%
Mar 2026
HK$66.50
−3.5%
Feb 2026
HK$68.90
−16.6%
Jan 2026
HK$82.65
−28.1%
Dec 2025
HK$115.00
−42.7%
Nov 2025
HK$200.60
―
Price13-week MA26-week MAHang Seng Index
3-Year HighHK$221.00Nov 3, 2025
3-Year LowHK$7.98Nov 12, 2026
Annualized Return−59.3%
Max Drawdown−96.4%
If you had invested HK$10,000 3 years ago, it would be worth HK$2,874 today (−71.3%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −1.1%, while this stock moved −71.3%.
Yearly Closes
Year
Year-End Close
Yearly %
2026 (YTD)
HK$7.98
−93.1%
2025
HK$115.00
―
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jun 2025). Please check the latest prices before trading.
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No.6Disclosure2026/11/01 19:14
内部情報（インサイド・インフォメーション）
INSIDE INFORMATION ANNOUNCEMENT GRANT OF LISTING APPROVAL BY THE STOCK EXCHANGE FOR IMPLEMENTATION OF THE H SHARE FULL CIRCULATION
事業の状況
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSED IN PHASE II CLINICAL TRIAL OF TINENGOTINIB IN COMBINATION WITH NOVEL HORMONAL THERAPY FOR PRETREATED AND PROGRESSED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CHINA
事業の状況
VOLUNTARY ANNOUNCEMENT INCLUSION OF YOCHANRA (TINENGOTINIB) IN THE CSCO GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF BILIARY TRACT CANCERS (2026)